INVITED LECTURESHIPS AND SPEAKING ENGAGEMENTS
American Health Sciences University and Academic Heath System in Namibia, Africa. MKP South Africa Group, Johannesburg South Africa, May19, 2018
21st Century Medicine, West Virginia University, Distinguished Professor Lecture, Robert C. Byrd Health Sciences Center, April 6, 2017
Of the importance of culture and common purpose: the evolution of Global Health, MHCC, Marrakech Morocco, January 20, 2017
Concept for a novel Health System to serve the West Coast of Africa, MHCC, Marrakech Morocco, November 21, 2016
Evolving care that is relevant, cost-effective and delivers value, The 6th U.S.-China Health Summit, September 3, 2016
Welcoming Remarks, “2015 Annual Society of Neurological Surgeons”, Mandarin Hotel, Miami, Florida, June 7, 2015
Welcoming Remarks, “McKnight Brain Research Foundation/Inter-Institutional Meeting”, Hyatt Regency, Miami, Florida, April 30, 2015
"New Advances in Interventional Cardiology", Women’s Lunch Bunch, Lauderdale Yacht Club, Fort Lauderdale, Florida, April 23, 2015
“Towards Personalized Cancer Medicine”, Miami Winter Symposium, Hyatt Regency, Miami, Florida, January 19, 2015
“Role in International Disaster Preparedness and Response – Lessons Learned and Current Gaps”, Humanitarian Assistance and Disaster Relief (HADR) Conference Expert Consultation Workshop--“Designing the Future of Disaster Preparedness and Responses Using Mobile Technology”, Ronald Reagan Building and International Trade Center, Rotunda Room, Washington, DC, July 23, 2014
“Advances and Treatment of Frailty”, Holy Cross Hospital Auditorium, Ft. Lauderdale, Florida, June 25, 2014
“Of Aging, Inflammation, Frailty, and Stem Cells”, 2014 International Society for Heart Research, Miami Beach Resort, Grande Promenade Room, Miami Beach, Florida, May 14, 2014
“Frailty”, Cardiology Grand Rounds, University of Miami Hospital Seminar Center, Miami, Florida, May 6, 2014
Inaugural Speaker, “Frailty”, Moorings Park Healthy Living, The Center for Healthy Living Theatre, Naples, Florida, July 11, 2013
“The Academic Medical Center under Obamacare – Promises and Problems,” MEDNAX Medical Directors Meeting, Hilton Orlando Bonnet Creek, Orlando, Florida, April 7, 2013
Welcoming Remarks, “Synergy 2012, A Multidisciplinary Approach to Interventional Oncology,” Fontainebleau Miami Beach Hotel, Miami Beach, Florida, November 9, 2012
"Eradication of Coronary Artery Disease: Goal for the 21st Century,” Future of Medicine Summit IV (Panel on Science, Medicine & Community: Latest Advancements in Cardiovascular Disease Research, Treatment & Care), Palm Beach County Convention Center, West Palm Beach, Florida, September 27, 2012
“Get at the Heart of the Matter: Atherosclerosis Genetics,” Genomic Medicine International Conference, JW Marriott Marquis Hotel, Miami, Florida, May 31, 2012
“Atherosclerosis Inflammation, Genetics and Stem Cell, 2011,” Medical Grand Rounds, JFK Medical Center, Kennedy Conference Rooms 1-3, Atlantis, Florida, March 29, 2012
“Atherosclerosis Inflammation, Genetics and Stem Cell, 2011,” Cardiology Grand Rounds, Leonard M. Miller School of Medicine, University of Miami Hospital Seminar Center A&B, Miami, Florida, March 20, 2012
“Genetics of Cardiac Disease“, Keynote Speaker -- Vaccine & Gene Therapy Institute Florida (VGTI) Grand Opening, Port St. Lucie, Florida, February 29, 2012
“Biomedical Innovations/Life Science and Technology Park (LSTP)”, RCA Miami and Realtor Association of Miami Conference, Biltmore Hotel – Country Club Ballroom, , Coral Gables, Florida, November 18, 2011
“Future of Cardiovascular Specialties”, Corazon’s Annual Conference, Hard Rock Casino – Grand Ballroom D, Corazon, Inc., Davie, Florida, October 19, 2011
“Personalizing Physical Exercise”, Obesity Symposium, Clinical Research Building – Gordon Center, University of Miami Miller School of Medicine, October 10, 2011
“The Future of Cardiovascular Research”, International Cardiovascular Conference – M3 2011, Fontainebleau Hotel, Miami Beach, Florida, October 5, 2011
“Medicine as an Ambassador to Peace”, Beckwith visiting Professor, Department of Medicine Grand Rounds, Rhode Island Hospital – George Auditorium, Warren Alpert Medical School of Brown University, Providence, Rhode Island, May 3, 2011
“What’s New at UHealth: South Florida’s Most Advanced Medical Care”, Collegetown UM Doctors Lecture Series, Robert and Judi Prokrop Newman Alumni Center, University of Miami Miller School of Medicine, Coral Gables, Florida, April 5, 2011
“Scientific Evidence Behind Minimally Invasive Approach”, Masters in Repair of Structural Heart Disease (MIRS) Conference, Doral Golf and Resort-Legends Ballroom, Miami, Florida, October 15, 2010
“The Emperor’s New Genes: Tale of Atherosclerosis”, Department of Cardiology Grand Rounds, University of Miami Hospital Seminar Center – Rooms A & B, University of Miami Miller School of Medicine, Miami, Florida, September 21, 2010
“Historical Background of Robotics in United States”, International Congress -- “Advances in Minimally Invasive Treatments (MIT)”, Ritz Carlton South Beach, Miami Beach, Florida, June 28, 2010
“Importance of Service to the Community & the Field of Science”, Commencement Ceremony Speaker, Ransom Everglades High School, Coconut Grove, Florida, May 28, 2010
“The Advantages of Global Collaboration”, Association of Academic Health Centers (AAHC) Inaugural Central and South America Meeting, University of São Paulo Medical School, Sao Paulo, Brazil, May 20 - 21, 2010, May 20, 2010
“Academic Health Centers Models”, Roundtable Discussion, Association of Academic Health Centers (AAHC) Inaugural Central and South America Meeting, University of São Paulo Medical School, Sao Paulo, Brazil, May 20 - 21, 2010, May 20, 2010
“Atherosclerosis, Stem Cells and Genetics”, Heart and Vascular Institute Grand Rounds, Bunts Auditorium, Cleveland Clinic, Cleveland, Ohio, April 30, 2010
“Genetics of Cardiovascular Diseases”, Cardiovascular Freshman Lecture, Auditorium 126, Florida Atlantic University, Boca Raton, Florida, April 22, 2010
"Genomics and Cellular Therapy-Implications for Cardiovascular Disease", Holy Cross Cardiovascular Symposium, Holy Cross Hospital, Sister Innocent Conference Center, Fort Lauderdale, Florida, April 10, 2010
“The Role of Human Rights in Professional Education”, 18th Annual Florida Ethics: Debates, Decisions, Solutions, Florida Bioethics Network Spring 2010 Conference, Miami Beach Resort and Spa, Miami Beach, Florida, April 9, 2010
“Rebuilding for Resilience/Haiti Reconstruction”, International Multidisciplinary Forum -- “Rebuilding for Resilience: How Science and Engineering Can Inform Haiti’s Reconstruction”, The Storer Auditorium, University of Miami, Coral Gables, Florida, March 22, 2010
"The Challenges of Medical Education in the Current Climate of Healthcare Reform", Annual Meeting of the Southeastern Section of the American Urological Association, Loews Hotel, Miami Beach, Florida, March 11, 2010
“Atherosclerosis, Stem Cells, Genetics”, Department of Medicine Grand Rounds Lecture, Northwestern University, Chicago, Illinois, March 2, 2010
“Cardiovascular Medicine (Where are we Heading?)”, Cardiovascular Congress 2010, Gordon Center for Research in Medical Education, University of Miami Miller School of Medicine, Miami, Florida, February 26, 2010
“Autonomous Innovations in Healthcare”, Institute of Medicine and the National Academy of Engineering Joint Regiional Meeting, The Storer Auditorium, University of Miami, Coral Gables, Florida, February 25, 2010
“Medical Knowledge in the IT Era”, Ralph H. and Ruth F. Gross Biennial Lecture, Louis Calder Memorial Library, University of Miami Miller School of Medicine, Miami, Florida, December 10, 2009
“Role of Mitochondria in the Biology of Reactive Oxygen Species”, MitoClub Seminar, University of Miami Miller School of Medicine, Miami, Florida, December 1, 2009
"Will US providers meet the competition form International Specialty Surgery Providers and their Rapid Advances in Healthcare Delivery Systems", Health Care Globalization Summit, Panel Participation, Miami, Florida, November 12, 2009
“Predicting Cardiovascular Illness in the 21st Century”, Keynote Address, 23rd Annual Meeting of the Florida Chapter of the American College of Cardiology, August 21 – 23, 2009, Lake Buena Vista, Florida, August 22, 2009
“Keeping Innovation Alive in the Brave New World of Health Care Finance and Regulation”, Roundtable Discussion, Thought Leaders Summit, March 12 - 14, 2009, Hollywood, Florida, March 13, 2009
“Cardiology 2020”, Cardiovascular Congress 2009, Miami Beach, Florida, February 19 – 21, 2009, February 20, 2009
“The Role of Genomics in the Prevention of Cardiovascular Disease”, Keynote Speaker, Harvard Medical School and the University of Miami Leonard M. Miller School of Medicine Pri-Med South 2009 Conference and Exhibition, Fort Lauderdale, Florida, February 15, 2009
“The Global Implications of Genomics”, Panel Discussion, University of Miami Global Business Forum, University of Miami, Coral Gables, Florida, January 16, 2009
“Predicting Cardiovascular Illnesses for the 21st Century, and the Unpredictable…”, Keynote Lecture, 2008 Dorothy M. Davis Heart & Lung Research Institute Retreat, The Ohio State University, Columbus, Ohio, October 28, 2008
“Myocardial Infarction, from Unstable Plaque to Progenitor Cells” Cardiology Grand Rounds Lecture, The Ohio State University, Columbus, Ohio, October 27, 2008
“Aligning Multiple Clinical Sites with the Academic Health Center Mission”, Panel Discussion, Association of Academic Health Centers 2008 Annual Meeting, Scottsdale, Arizona, October 16 – 18, 2008, October 18, 2008
“Genes, Stem Cells and CAD”, Transcatheter Cardiovascular Therapeutics Conference, Washington, D.C., October 12 – 17, 2008, October 14, 2008
“Predicting Cardiovascular Illnesses for the 21st Century”, University of Miami/University of Pisa Third Course in Dermacosmetology, Pisa, Italy, September 16, 2008
“Medical Education in the 21st Century”, Society for Education in Anesthesia 2008 Spring Annual Meeting, Miami Beach, Florida, June 6, 2008
"Stem Cell and Atherosclerosis", 14th Annual International Society for Cellular Therapy (ISCT) Meeting, Miami, Florida, May 20, 2008
“Heart Healthy at Any Age,” Women’s Health Day Lecture, University of Miami Hospital, Miami, Florida, May 17, 2008
“Genes, Stem Cells and CAD,” Cardiology Grand Rounds, University of Pittsburgh Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, May 13, 2008
“Perspective on Future of Genomics”, Miami Institute for Human Genomics Genetic Analysis of Complex Human Diseases Course, Miami, Florida, May 5 – 8, 2008, May 7, 2008
“Miami: A Medical Destination”, Greater Miami Chamber of Commerce, Miami, Florida, May 7, 2008
"Remarks about Regional Medical Campuses from a Dean's Perspective", Association of American Medical Colleges, Group on Regional Medical Campuses Spring Meeting April 9 – 11, 2008, Boca Raton, Florida, April 10, 2008
“Miami-Dade as a Medical Destination”, American College of Cardiology Florida Chapter, 30th Annual Cardiovascular Symposium, February 21 – 24, 2008, Hollywood, Florida, February 22, 2008
“Aging: not just the passage of time”, Veterans’ Administration Geriatrics and Gerontology Grand Rounds Miami, Florida, February 21, 2008
"Vaccine, the best human prevention yet", Neonatology 2007: Association of Administrators in Academic Pediatrics (AAAP), Miami, Florida, November 8, 2007
"Cardiac Genomics", South Miami Heart Center 2007 Comprehensive Cardiovascular Conference, Coral Gables, Florida, October 19, 2007
"At the leading edge of medicine: from genomic prevention to robotic surgical solutions", Fundamentals of Translational Science, Miami, Florida, September 21, 2007
“Genomics of Cardiovascular Disease”, Baptist Hospital South Florida Cardiovascular Conference, Miami, Florida, September 20, 2007
"Burden of Atherothrombosis: Mechanisms and Pathology on Vascular Cell Morphology and Repair", AHA-4th Symposium of the Burden of Therosclerotic Disease: Diagnosis and Therapy, New York, New York, June 9, 2007
"Effects of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes", Cardiovascular Disease Forum Journal Club, Miami, Florida, June 6, 2007
“Synecor: A New Paradigm for Rapid Commercialization of Medical Terminology", Miami, Florida, May 8, 2007
"Arterial Disease and Repair", InterAmerican Society of Hypertension and Consortium for SE Hypertension Control, Miami, Florida, May 5, 2007
“The Genomics of Atherosclerosis and CAD”, Preventive Cardiovascular Therapeutics Symposium, Coral Gables, Florida, April 20, 2007
“Aging and the Heart”, Biology of Aging Seminar, Miami, Florida, March 20, 2007
“The Genomics of Atherosclerosis”, Ochsner Clinic Foundation and Health Systems Basic Science in Clinical Medicine Lecture Series, Medical Grand Rounds, New Orleans, Louisiana, March 12 - 13, 2007
“Myocardial Infarction: From ST-Elevation to Genomics",15th Annual Miriam Lemberg Visiting Professorship in Cardiovascular Disease Lecture, Department of Medicine Grand Rounds, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida, March 7, 2007
"Generation G-for Genome-and the Legacy of the Boomers", Rodney Howell Lecture. Leonard M. Miller School of Medicine, University of Miami, Miami, Florida, February 23, 2007
"Endothelial Cell Therapy and Aging”, Veterans’ Affairs Medical Center Geriatric Institute Grand Rounds, Miami, Florida, February 15, 2007
"How to have your steak and live to enjoy it”, 5th Annual Miami International Revascularization Summit, Miami, Florida, February 9, 2007
"New Jenner-ation”, 2007 Biotech Symposium, Miami, Florida, January 28, 2007
“How to Have Your Steak and Live to Enjoy It, Too”, 42nd Annual Postgraduate Course of Internal Medicine Update 2007, Miami, Florida, January 23, 2007
“Aging of endothelial precursors”, National Institutes of Health Angiogenesis in the Nervous System Workshop, Bethesda, Maryland, December 12, 2006
“Checkmate!” IBM and Scripps Telephone Conference, November 17, 2006
“How to Have Your Steak and Live to Enjoy It, Too”, Nutrition, Fitness and Global Health Conference, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida, November 11, 2006
“Diversity in Medicine”, Southeastern American Medical Student Association (AMSA), Leonard Miller School of Medicine, University of Miami, Miami, Florida, November 10, 2006
“Educating Doctors: The International Era”, Medical Grand Rounds, Leonard Miller School of Medicine, University of Miami, Miami, Florida, October 3, 2006
“How to Enjoy your Steak and Eat It, Too”, Medical Grand Rounds, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida, June 30, 2006
“Of Aging, Cellular Repair and Atherosclerosis”, Lillehei Heart Institute, University of Minnesota, Minneapolis, Minnesota, November 29, 2005
“Session-Restenosis, Atherosclerosis, and Angiogenesis-Is There a Link? Stem Cells and Plaque Growth”, American Heart Association Scientific Sessions, Dallas, Texas, November 13, 2005
“Anemia, Cytokines, and Bone Marrow Responses on Cardiovascular Function”, Amgen, Anemia: A Modifiable Risk Factor for Heart Disease, American Heart Association Scientific Sessions, Dallas, Texas, November 12, 2005
“Genome Expressions Profiling”, Session-From Genome to Phenome: The Translational Biology of Cardiovascular Disease, American Heart Association Scientific Sessions, Dallas, Texas, November 12, 2005
“Designer Genes: From Plaque to Attack-Introducing novel Genomic and proteomic markers of atherosclerosis versus atherothrombosis”, AEHA, SHAPE Task Force Symposium, American Heart Association Scientific Sessions, Dallas, Texas, November 12, 2005
“Arterial Repair, Atherosclerosis, Bone Marrow Problems”, 3rd Annual Nathan W. Shock Aging Symposium, Stem Cells: Regenerative Medicine?, Towson, Maryland, September 30, 2005
“Aging, Stem Cells and Coronary Artery Disease”, International Heart Forum Beijing 2005, Beijing, China, September 16, 2005
“Failure of Arterial Repair with Aging Leads to Atherosclerosis”, Boston Medical Center, Boston, Massachusetts, September 13, 2005
“Arterial Homeostasis, Inflammation, and Erythropoietic Growth Factors”, Amgen, Anemia: A Modifiable Risk Factor for Heart Disease” Roundtable, Boston, Massachusetts, July 15, 2005
“Cell Therapy Solutions for Arterial Disorders”, Cardiology Grand Rounds, University of California, San Francisco, California, May 18, 2005
“Cell Therapy Solutions for Arterial Disorders”, American Society of Hypertension, San Francisco, California, May 16, 2005
“Progenitor Cells in Cardiovascular Disease”, Society of Vascular Surgery, Washington, D.C., April 8, 2005
“Arterial Inflammation and Repair in Atherosclerosis and CAD”, New York University Medical Center, New York, New York, March 22, 2005
“Cell-Based Therapy: Myth or Reality”, American College of Cardiology Scientific Sessions, Orlando, Florida, March 8, 2005
“Functional Genomics”, American Society of Hypertension, Inc., Naples, Florida, January 15, 2005
“The Era of Bone Marrow Derived Repair – Competent Cells for Atherosclerosis”, NIA Stem Cells and Aging Meeting, Bethesda, Maryland, November 10, 2004
“Gene Expression Studies of Atherosclerosis”, American Heart Association Scientific Sessions, New Orleans, Louisiana, November 7, 2004
“Cardiovascular Genetics, Genomics, and Proteomics”, Transcatheter Cardiovascular Therapeutics, Washington, D.C., September 27, 2004
“The Era of Cell Therapy for Cardiovascular Disease”, SingHealth Grand Rounds, Singapore National Heart Centre, Singapore, July 22, 2004
“Vascular Progenitor Cells and Atherosclerosis”, Richard V. Ebert Visiting Professor Medicine Grand Rounds, University of Arkansas for Medical Sciences, Little Rock, Arkansas, July 15, 2004
“Vascular Progenitor Cells and Atherosclerosis”, Medical Center Medicine Grand Rounds
New York, New York, July 7, 2004
“Defining the PCI Patient Who Benefits from GP Iib/IIIa Inhibition”, 2004 Report Card on Interventional Coronary Management, Chicago, Illinois, June 12, 2004
“Vascular Progenitor Cells and Atherosclerosis”, Tulane-LSU Medicine Grand Rounds, Tulane University Health Science Center, New Orleans, Louisiana, June 2, 2004
“Current Controversies in Acute Coronary Syndromes”, Cardiology Grand Rounds, Case Western Reserve University, Cleveland, Ohio, May 13, 2004
“Novel Clues on the Aging Risk in Atherosclerosis and ACS”, The Frank N. Wilson Visiting Professor, Cardiology Grand Rounds, University of Michigan Health System, Ann Arbor, Michigan, May 11, 2004
“Atherosclerosis: From Genomics to Clinic”, Cardiology Grand Rounds, University of Rochester Med Center, Rochester, New York, April 27-28, 2004
“From Bench to Bedside to Boardroom”, “Bone Marrow Derived Pluripotential Cells in Atherosclerosis”, Society of Vascular Surgery Translational Vascular Research, Bethesda, Maryland, April 1, 2004
“Rac1 Regulation of the Cardiovascular System”, 2nd Annual International Conference on NAD (P) H Oxidases (NoxII), Pine Mt., Georgia, March 30 - 31, 2004
“Progenitor Cell Based Therapeutic Strategies for Atherosclerosis”, Doris Duke Clinical Scientist Meeting, Cold Spring Harbor, New York, March 20 - 21, 2004
103.“Platelet Phenotyping and Quality Control Issues”, Johns Hopkins GeneSTAR Meeting, Baltimore, Maryland, March 19, 2004
“Genomics of Cardiovascular Disease”, Eighth Duke Advanced Interventional Cardiology Symposium, Vail, Colorado, January 15-18, 2004
“Bench: Stem Cell Plascity: Are Myogenesis and Angiogenesis Possible?”, “The Aging Vasculature – Cellular Senescence and Atherogenesis”, NHLBI, SCCOR Vascular Diseases in Research Priority Panel, Bethesda, Maryland, December 10-11, 2003
“Going Nano: To The Vessel and Beyond”, Session Moderator, American Heart Association Meetings, Orlando, Florida, November 9-10, 2003
“New Clues to Cardiovascular Aging”, Johns Hopkins Cardiology Update – 2003, Captiva Island, Florida, October 10, 2003
“On the Memory of Chronic Illness: The Case for Atherosclerosis”, First Annual Shupar Naimi Lecture in Cardiology, Tufts New England Medical Center, Boston, Massachusetts, September 30, 2003
“Diagnosis and Therapeutic Approaches to ASCVD in the Genomics Era”, “A Primer of Genetics and Proteomics for the Cardiologist”, “Theory Behind Stem Cells and Cardiovascular Repair”. Discussant, “How and When Will Genetic Profiling Impact Patient Care?”, “When and Which Gene Therapies Will Become Mainstream?” Transcatheter Cardiovascular Therapeutics Meeting, Washington, D.C., September 15, 2003
Co-Chair, Genetics of Cardiovascular Disease Roundtable, Pentagon City, Virginia, September 12-13, 2003
“Understanding the Healing Artery: From Thrombosis to Lesion Passivation”, Experts on the Evidence: Prevention and Management of Thrombus in Acute Coronary Syndrome, European Society of Cardiology meeting, Vienna, Austria, September 2, 2003
“Genetics of Coronary Artery Disease” and “Controversies in Cardiology: Detection of Unstable Plaque: What is Best Technique?” The Simon Dack Visiting Professorship, Mt. Sinai Medical Center, New York, New York, June 23, 2003
113.“Translation of Scientific Discoveries on Atherosclerosis into Clinically Relevant Strategies”, Cardiology Grand Rounds, University of Virginia, Charlottesville, Virginia, December 3, 2002
“Basic Mechanisms Underlying Plaque Stability”, American Heart Association Meeting, Chicago, Illinois, November 16, 2002
“The Future of Cardiology”, Corazon Annual Conference, Naples, Florida, October 2, 2002
“Inflammation in PCI”, TCT Symposium, Sept. 25, 2002, “Diagnosis and Therapeutic Approaches to ASCVD in the Genomics Era”, Washington, D.C., September 26, 2002
“Etiology of Atherosclerosis: A Genomic Look”, Intervention 2002, Atlanta, Georgia, September 6, 2002
“Current Understanding of the Pathophysiology of Arterial Thrombosis”, European Society of Cardiology, Berlin, Germany, September 3, 2002
“GPIIIb/IIIa Inhibition and a Drug Eluting Stent”, European Society of Cardiology”, Berlin, Germany, September 1, 2002
“ACC/AHA Guideline Updates 2002”, Takoma Park, Maryland, August 23, 2002
“Beyond the Platelets: Plaque Stabilization-Survival Mechanisms of Abciximab”, Bethesda, Maryland, August 20, 2002
“Implications of Human Genoma in Cardiovascular Disease”, X Simposio International de Cardiopatia Isquemica, Bilbao, Spain, May 22-24, 2002
“Endothelial Function in Vascular Disease”, 42nd Annual Conference on Cardiovascular Disease Epidemiology and Prevention, American Heart Association, Honolulu, Hawaii, April 26, 2002
“Atherosclerosis and Genetics”, Medicine Grand Rounds, Union Memorial Hospital, Baltimore, Maryland, April 25, 2002
“Genomics to Genetics – A Different Approach to Atherosclerosis”, Medicine Grand Rounds, Louisiana State University Medical Center, Shreveport, Louisiana, March 26, 2002
Merck Platelets and Cardiovascular Treatments Symposium, 51st Annual ACC Scientific Sessions, “Pride, Esprit”, Atlanta, Georgia, March 17, 2002
“Human Genetic Affect on Coronary Artery Disease”, 12th Annual Cardiology Symposium, Halifax Regional Hospital, South Boston, Virginia, March 5, 2002
“Progress in Atherosclerosis and CAD: Genomics and Proteomics”, Cardiology Grand Rounds, Baylor College of Medicine, Houston, Texas, February 21, 2002
“Atherosclerosis: The Genomic Era”, 11th Annual Cardiovascular Conference at Beaver Creek, Beaver Creek, Colorado, February 11, 2002
“Searching for the Rosetta Stone of Atherosclerosis”, Cardiology Grand Rounds, Albert Einstein University, Montefiore Medical Center, Bronx, New York, January 29, 2002
“Antiplatelet Therapy”, Walter Reed Symposium, Womack Army Medical Center, Fayetteville, North Carolina, December 12, 2001
“Platelet Control in Acute Coronary Syndromes, from Therapeutics to Pharmacogenetics”, Cardiology Grand Rounds, Mayo Clinic, Rochester, Minnesota, November 30, 2001
“A New Standard of Care in Acute Coronary Syndromes”, Cardiology Grand Rounds, University of Minnesota Hospital, Minneapolis, Minnesota, November 29, 2001
“Managing Atherothrombosis: Implications of Recent Clinical Trials”, Cardiology Grand Rounds, Gunderson Lutheran Medical Center, La Crosse, Wisconsin, November 28, 2001
Cardiology Conference, University of Miami Hospital, University of Miami School of Medicine, Miami, Florida, 2001
“Pathogenesis of Plaque Instability: A Paradigm Shift in Concept”, Eli Lilly Satellite Symposium, “2001-A Year in Perspective – Spotlight on the Heart during 74th AHA Annual Scientific Sessions, November 11, 2001
“Genetics of Heart Disease: Tailoring Treatment and Prevention”, AMA Reporters Conference, San Francisco, California, October 29, 2001
“Platelet Physiology, Pathology and Genetics in Acute Coronary Syndromes”, Georgia Chapter Annual Scientific ACC Meeting, Savannah, Georgia, October 20, 2001
“Atherosclerosis, From Genetics to Therapeutics”, Cardiology Grand Rounds, The Johns Hopkins Medical Center, Baltimore, Maryland, October 10, 2001
“Elimination of Coronary Heart Disease by 2050”, Margolis Lecture, Johns Hopkins University, Baltimore, Maryland, September 24, 2001
“Pharmacogenetics”, Intervention 2001, Atlanta, Georgia, September 6, 2001
“Therapeutics for Acute Coronary Syndromes – the Post CURE Era”, Cardiology Grand Rounds, Mt. Sinai Medical Center, Miami, Florida, August 29-30, 2001
“DNA Methylation and Atherosclerosis”, Diet, DNA and Methylation Processes and Health Workshop, National Institute of Health: Bethesda, Maryland, August 7, 2001
“Cardiovascular Disease: Advances in the Treatment and Prevention – The Role of Antiplatelet Agents”, Cardiology Grand Rounds, Tulsa Regional Medical Center, Tulsa, Oklahoma, June 27, 2001
“Platelet Inhibition in Acute Coronary Syndromes: From Bench to Bedside”, Cardiology Grand Rounds, Westchester Medical Center, Valhalla, New York, May 8, 2001
“The Human Genome Project - What Does it Mean to Cardiologists?” 5th Annual Duke-Pinehurst Stent Symposium, Pinehurst, North Carolina, May 5, 2001
Cardiology Grand Rounds, Columbia University, New York, New York, May 2001
“Platelet Glycoprotein (GPIIIa) Variants, Coronary Thromboembolism and Response to Aspirin”, Experimental Biology 2001, Orlando, Florida, April 2, 2001
“Cardiovascular Genomics and Molecular Imaging”, Radiology Grand Rounds, Duke University Medical Center, Durham, North Carolina, March 29, 2001
“Thrombotic Complications and Cardiovascular Disease”, Medicine Conference, Durham Regional Hospital, Durham, North Carolina, March 28, 2001
“Bringing Internet Access and Genomics to Cardiovascular Outcomes Research”, Linking Internet Technology and Duke’s Cardiovascular Databases to Explore Clinical Drug Development Questions, Orlando, Florida, March 19, 2001
“Genetics of Cardiovascular Disease – Impact of Human Genome Project for Cardiovascular Disease”, ACC 50tth Annual Scientific Sessions, Orlando, Florida, March 19, 2001
“Eradication of Coronary Artery Disease by 2050”, Heart Center Grand Rounds, Cleveland Clinic Foundation, Cleveland, Ohio, March 7, 2001
“The Role of Rac and NADPH Oxidase in Hypertension”, Lerner Research Foundation, Cleveland Clinic Foundation, Cleveland, Ohio, March 6, 2001
“An Essay on Longevity, Heart Disease and Your Gene Pool”, Palm Beach, Florida, March 2, 2001
“Inflammation and Thrombosis: From Pathophysiology to Therapy”, 2001 Cardiology Symposium, Raleigh, North Carolina, February 17, 2001
“Platelet Polymorphisms” Tenth Annual Cardiovascular Conference, Beaver Creek, Colorado, February 14, 2001
“Immediate Implications of the Human Genome Project for Cardiology”, Tenth Annual Cardiovascular Conference at Beaver Creek, February 12, 2001
Revolutionizing Ischemic Vascular Disease Management, “Beyond the Platelets: Plaque Stabilization- Survival Mechanisms of Abciximab”, Washington Hospital Center, Washington, D.C., January 31, 2001
“Cardiovascular Disease: Advances in Treatment and Prevention – The Role of Antiplatelet Agents”, Cardiology Grand Rounds, UCSF Medical Center, San Francisco, California, January 24, 2001
“News and Views on the Pathophysiology and Treatment of Acute Coronary Syndromes”, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, January 12, 2001
“Acute Coronary Syndromes: New and Views on Therapies”, Weill Medical College, Cornell University, New York, New York, December 18, 2000
“New Mechanisms of Plaque Destabilization”, Good Samaritan Hospital, Dayton, Ohio, December 13, 2000
“Genetics and Pharmacogenomics of Unstable Coronary Syndromes”, Medicine Grand Rounds, William Beaumont Hospital, Royal Oak, Michigan, December 6, 2000
“Vascular Cell Growth: Basic Mechanisms”, 73rd AHA Scientific Sessions, New Orleans, Louisiana, November 12, 2000
“Platelet Management and Beyond in Acute Coronary Syndromes: A Multifactorial Approach”, Beyond the Platelets: Plaque Stabilization-Survival Mechanisms of Abciximab, New Orleans, Louisiana, November 11, 2000
“New Advances in Antiplatelet Therapy”, Emerging Trends in the Management and Treatment of Atherosclerosis, Chicago, IL, October 21, 2000 and Hot Springs, Virginia, October 27, 2000
“Genetic Mapping to Direct Customized Therapies”, Transcatheter Cardiovascular Therapeutics (TCT) Symposium, Washington, D.C., October 18, 2000
“Thrombosis and Inflammation: Inseparable Processes in Acute Coronary Syndromes”, Cardiology Update 2000 Symposium, Heart and Lung Institute, The Ohio State University, Columbus, Ohio, October 13, 2000
“Platelet Function” Effects of Estrogen on Thrombosis and Inflammation, Graylyn Conference on Women’s Health, Winston-Salem, North Carolina, October 12, 2000
“Human Genotyping”, Current Concepts in the Diagnosis and Treatment of Adult Heart Disease, Pensacola, Florida, October 6, 2000
“New Treatments with Antiplatelet Agents,” Charlotte, North Carolina, September 30, 2000
“Unmet Needs and Potential Applications: Cardiology”, BioMEMS & Biomedical Nanotechnology World 2000, Columbus, Ohio, September 26, 2000
“Overview of IIB/IIIA Field-Where are we going?” Treatment Strategies for Acute Coronary Syndromes, Pinehurst, North Carolina, September 23, 2000
“Pharmacogenomics of Coronary Thrombosis,” Grand Rounds, University of Michigan,
Ann Arbor, Michigan, September 19, 2000
“Nano-Cardiology: Are we there yet?” Biomedical Engineering Seminar Series, Duke University Medical Center, Durham, North Carolina, September 15, 2000
“New Advances in Molecular-Based Imaging,” Intervention 2000 - Critical Review of Interventional Technology and Interventional Catheterization Skills, Atlanta, Georgia, September 9, 2000
9th Annual Seminar on Molecular Pathology, William Beaumont Hospital, Royal Oak, Michigan, April 14, 2000
“Genetics and Pharmacogenetics of Ischemic Heart Disease”, Grand Rounds, Duke University Medical Center, Durham, North Carolina, January 31, 2000
“Gene Therapy and Heart Disease”, Grand Rounds, Case Western Reserve, Cleveland, Ohio, December 16, 1999
“New Advances in Antiplatelet Therapy”, Grand Rounds, University of Cincinnati, Cincinnati, Ohio, December 7, 1999
“Pathogenesis and Genetics of Atherosclerosis”, Grand Rounds, The Ohio State University Medical Center, Columbus, Ohio, November 4, 1999
“Platelet Inhibition in Acute Coronary Syndromes: From Bench to Bedside”, Grand Rounds, Mt. Carmel Medical Center, Columbus, Ohio, October 26, 1999
First Annual Kyrenia Cardiovascular Center Symposium, New York Hospital Medical Center, Queens, New York, October 19, 1999
“Current Management of Acute Coronary Syndromes”, Grand Rounds, Queen’s Medical Center, Honolulu, Hawaii, September 1, 1999
“New Advances in Antiplatelet Therapy”, Grand Rounds, Wright Patterson Air Force Base, Dayton, Ohio, July 8, 1999
“Molecular Medicine from Gene to Therapy”, Symposium, Cleveland Clinic Foundation, Cleveland, Ohio, June 4, 1999
“The Role of Glycoprotein Iib-IIIa Platelet Inhibitors,” Grand Rounds, Vanderbilt University, Nashville, Tennessee, June 2, 1999
“Molecular Basis of Atherosclerosis,” Grand Rounds, Fawcett Center, Department of Pathology, The Ohio State University, Columbus, Ohio, May 6, 1999
“Genetic and Pharmacogenetic Aspects of Unstable Ischemic Coronary Events”, Grand Rounds, University Hospitals of Cleveland, Cleveland, Ohio, April 29, 1999
“New Advances in Antiplatelet Therapy”, Grand Rounds, Case Western Reserve University, Cleveland, Ohio, April 28, 1999
“Oxidants in mitogenic signaling and cell motility” American Physiological Society Annual Meeting, Washington, D.C., April 19-20, 1999
“Genetic Traits and Pharmacogenomics for Heart Attacks”, Grand Rounds, University of Pennsylvania, Philadelphia, Pennsylvania, April 8, 1999
Grand Rounds, “Genetic Traits and Pharmacogenomics for Heart Attacks,” Boston University, Boston, Massachusetts, April 5-6, 1999
“Platelet Glycoprotein IIIa Polymorphism and Risk for Coronary Thrombosis”, 8th Annual Seminar on Molecular Pathology, William Beaumont Hospital, Royal Oak, Michigan, March 26 - 27, 1999
“Genetic Traits in Pharmacogenomics for Heart Attacks,” Grand Rounds, Kettering Memorial Hospital, Dayton, Ohio, 1999
“Genetic Traits and Pharmacogenomics for Heart Attacks,” Grand Rounds, Wright State University, Dayton, Ohio, February 25, 1999
“Genetic Traits and Pharmacogenomics for Heart Attacks,” Grand Rounds, University of Minnesota, Minneapolis, Minnesota, February 18, 1999
“The Role of Oxidants in Cell Motility and Survival,” Grand Rounds, Department of Pharmacology Medical College of Ohio, Toledo, Ohio, February 17, 1999
“Antiplatelet Therapy: Utilizing Genetic Analysis”, Grand Rounds, Division of Cardiology Medical College of Ohio, Toledo, Ohio, October 15, 1998
“Perfusion: Then and Currently”, Fall 1998 AMSECT Region V Meeting, Columbus, Ohio, October 10, 1998
“Acute Coronary Syndromes and PlA2”, Grand Rounds, University of Pittsburgh, Pittsburgh, Pennsylvania, October 8, 1998
Symposium on Atrial Fibrillation and Antiplatelet Therapy: 1998 and Beyond, Cleveland, Ohio, September 19, 1998
“Prospective on Genetics and Cardiovascular Disease”, Cleveland Clinic Foundation Summit on Cholesterol and Coronary Risk, Cleveland, Ohio, September 3, 1998
“Platelet Glycoproteins,” Speaker, XX Congress of the European Society of Cardiology Vienna, Austria, 1998
“Can Genomic Therapeutics be Applied in Managing Unstable Coronary Syndrome?”, Grand Rounds, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, 1998
“The Advances in Molecular Cardiology: Hope for the Future or Simply Hype?” 11th Annual Cardiology Symposium, Columbus, Ohio, 1998
“Post Translational Signaling”, 21st Annual Conference on Shock, San Antonio, Texas, 1998
“Risk Factors in Coronary Thrombosis”, 28th Annual Postgraduate Medical Seminar, Portsmouth, Ohio, 1997
,“From Genes to Myocardial Infarction: Frontiers of Cardiovascular Science and Medicine in the 21st Century”, Division of Cardiology Spring Conference, The Ohio State University, Columbus, Ohio, 1997
“Superoxide: Unexpected Mediator of Cell Signaling”, The Cleveland Clinic Foundation, Cleveland, Ohio, 1997
“Genes and Coronary Thrombosis”, XIX Congress of the European Society of Cardiology, Stockholm, Sweden, 1997
“New Genetic Factors in Ischemic Heart Disease”, Grand Rounds, Department of Medicine, Columbia Presbyterian Medical Center, New York, New York, 1997
Keystone Symposia on Molecular and Cellular Biology, Keystone, Colorado, 1996
FASEB-Meeting, Physiology and Pathology of the Splanchnic Circulation, Copper Mountain, Colorado, 1996
“Coronary Heart Disease and Atherosclerosis a Preventable Condition,” St. Mary’s Medical Center & Good Samaritan Medical Center, Intracoastal Health Systems, Inc., West Palm Beach, Florida, 1996
“Cytoskeleton Dynamics in Health and Disease”, 4th Yale Cell Biology Symposium Peripheral ,Yale University, School of Medicine, New Haven, Connecticut, 1996
“Thrombosis in Myocardial Infarction Trialist Meeting,” Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, 1995
Lecturer and Chairperson International Meeting on Cytoskeleton and Cancer, Embiez, France, 1995
Lecturer and Session Chairman, Jacques Monod Conferences 1995 Morphogenic Functions of Actin-Associated Proteins, Aussois, France, 1995
Johns Hopkins Medical and Surgical Association Biennial Meeting, Baltimore, Maryland, 1995
Basic Seminar Physiology Department, University of Southwestern Texas, Dallas, Texas, 1995
Cardiology Grand Rounds, University of Massachusetts, Worcester, Massachusetts, 1995
Vascular Biology Seminar, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts, 1995
Cardiology Grand Rounds, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts, 1995
Medical Grand Rounds, Johns Hopkins University School of Medicine, Baltimore, Maryland, 1994
67th Scientific Sessions AHA, American Heart Association, Dallas, Texas, 1994
Gordon Research Conference on Hemostasis, Proctor Academy, Andover, New Hampshire, 1994
43rd Annual Scientific Session American College of Cardiology, Atlanta, Georgia , 1994
Vascular Medicine and Atherosclerosis Unit, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, 1994
Experimental Medicine Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, 1994
Medical Grand Rounds, Johns Hopkins University, School of Medicine, Baltimore, Maryland, 1994
State of the Art Lecturer, XIVth Congress of the International Society on Thrombosis and Hemostasis, New York, New York, 1993
Cold Spring Harbor Meeting on Cytoskeleton and Cell Function Meeting, Cold Spring Harbor, New York, 1993
Nicholson Lecture, Tuft University, Boston, Massachusetts, 1993 3rd Abercrombie Symposium, Cell Behaviour: Adhesion & Motility, Society for Experimental Biology British Society for Cell Biology, University of Bath, England, 1992
Gordon Research Conference, Motile & Contractile Systems, Plymouth, New Hampshire, 1992
Medical Grand Rounds, Johns Hopkins University, School of Medicine, Baltimore, Maryland, 1992
Actin 1992” Meeting, Albany, New York, 1992
Department of Medicine, University of Michigan, Ann Arbor, Michigan, 1992
Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, 1992
Syntex Laboratories, Syntex Scholars Program, Palo Alto, California, 1992
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee, 1992
Division of Cardiology, University of Cincinnati, Cincinnati, Ohio, 1992
American Society of Cell Biology Meeting, Boston, Massachusetts, 1991
193rd Annual Meeting of the Medical and Chirurgical Faculty of Maryland, University of Maryland, College Park, Maryland, 1991
Interurban Clinical Club Meeting, Johns Hopkins University School of Medicine,
Baltimore, Maryland, 1991
Finalist, Katz Prize Competition, American Heart Association Meeting, Dallas, Texas, 1990
Research Lecture, National Cancer Institute, Bethesda, Maryland, 1990
Seminaire Extraordinaire, Erasme Academic Hospital, Brussels, Belgium, 1990
Cardiology Division Research Lecture Series, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, 1990
Joint Meeting of the Societies for Cell Biology and for Biochemistry and Molecular Biology, San Francisco, California, 1989